These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11260019

  • 1. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 2. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S.
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [Abstract] [Full Text] [Related]

  • 4. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [Abstract] [Full Text] [Related]

  • 5. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009 Jul; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003 May; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 8. Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study.
    Fallah Arani S, Waalboer Spuij R, Nijsten T, Neumann HA, Thio B.
    J Dermatolog Treat; 2014 Feb; 25(1):46-9. PubMed ID: 22998609
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.
    Daudén E, Pedraz J, Alvarez-Ruiz S, García-Río I, Sánchez-Peinado C, Oñate MJ, García-Diez A.
    Eur J Dermatol; 2010 Feb; 20(3):321-2. PubMed ID: 20146966
    [Abstract] [Full Text] [Related]

  • 10. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [Abstract] [Full Text] [Related]

  • 11. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, van de Kerkhof PC, De Jong EM.
    Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
    [Abstract] [Full Text] [Related]

  • 12. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC, Morris-Jones R, Powles AV, Fry L.
    Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
    [Abstract] [Full Text] [Related]

  • 13. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
    Buell C, Koo J.
    J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
    [Abstract] [Full Text] [Related]

  • 15. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM.
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [Abstract] [Full Text] [Related]

  • 17. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD.
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB, Perkins AC, Van Cott A, Kimball AB.
    Am J Clin Dermatol; 2010 Oct; 11(4):275-83. PubMed ID: 20513160
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005 Dec; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.